Therapeutic cleavage of IgG: new avenues for treating inflammation.
about
A recombinant vaccine effectively induces c5a-specific neutralizing antibodies and prevents arthritisMaternal Anti-Fetal Brain IgG Autoantibodies and Autism Spectrum Disorder: Current Knowledge and its Implications for Potential TherapeuticsEngineered protease-resistant antibodies with selectable cell-killing functions.Targeting IgG in Arthritis: Disease Pathways and Therapeutic Avenues.
P2860
Therapeutic cleavage of IgG: new avenues for treating inflammation.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@ast
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@en
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@nl
type
label
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@ast
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@en
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@nl
prefLabel
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@ast
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@en
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@nl
P356
P1433
P1476
Therapeutic cleavage of IgG: new avenues for treating inflammation.
@en
P2093
Rikard Holmdahl
P304
P356
10.1016/J.IT.2008.01.007
P577
2008-03-06T00:00:00Z